Humanwell is the largest supplier of analgesics (post-operative) in China and has the most comprehensive anesthesia product portfolio in the world. With more than 4,000 sales professionals, the largest holding subsidiary Yichang Humanwell promotes its product portfolio in all major hospitals in China and holds more than 60% of the analgesics market share. Humanwell actively develops overseas markets. Its products have been registered and sold in 50 countries and regions, and 17 high-end sustained-release drugs have been approved by the US FDA.